Price target
372.200.000.00%
The 15 analysts offering 1 year price forecasts for MDGL have a max estimate of — and a min estimate of —.
Analyst rating
Based on 17 analysts giving stock ratings to MDGL in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
MDGL EPS for the last quarter is −4.92 USD despite the estimation of −6.75 USD. In the next quarter EPS is expected to reach −4.51 USD. Track more of Madrigal Pharmaceuticals, Inc. financials and stay on top of what is up with the company.
In the next quarter Madrigal Pharmaceuticals, Inc. revenue is expected to reach 87.37 M USD. Check out Madrigal Pharmaceuticals, Inc. revenue and earnings and make informed decisions.
According to analysts, MDGL price target is 372.20 USD with a max estimate of 530.00 USD and a min estimate of 155.00 USD. Check if this forecast comes true in a year, meanwhile watch Madrigal Pharmaceuticals, Inc. stock price chart and keep track of the current situation with MDGL news and stock market news.
We've gathered opinions of 17 analysts rating MDGL stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.